Global Pregnancy Anemia Market, By Type (Iron-Deficiency Anemia, Folate-Deficiency Anemia, Vitamin B12 Deficiency), Treatment (Folic Acid Supplements, Iron Supplement, Others), End-Users (Clinics, Hospitals, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Global Pregnancy Anemia Market
Pregnancy anemia market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 4.80% in the above-mentioned research forecast period. Rising cases of haemodilution in pregnancy and increasing population of pregnant women during COVID-19 among others.
High demand of new treatment options and various product launches also boost up the market growth. Moreover, increasing partnership and collaboration among market players and favourable government support for better women health acts as opportunity for the market growth. But, presence of alternative herbal products and strict regulatory guideline may hamper the global pregnancy anemia market.
Pregnancy anemia is characterized by too few red blood cells among women which results in low oxygen presence in sufferer women. This lack of oxygen affects the activities of nerves and muscle tissue and hence ultimately affects the overall body processes. Moreover during pregnancy developing foetus also requires efficient blood which makes the mother anaemic if proper diet and supplement not provided. The presence of strict vegetarian women population is at higher risk of pregnancy anemia and thus heavily relies on other supplementary products in order to fulfil body requirements. The common associated symptoms of pregnancy anemia include pale skin, tiredness, trouble concentrating, rapid heartbeat, labored breathing among others. Pregnancy anemia can be treated with the uptake of ferrous ammonium citrate, ferrous iron sulphate, iron dextran, multivitamin, folic acid derivatives, among others.
As per the WHO report approximately 40% pregnant women worldwide are anaemic which relies on supplements and drugs so as to meet the RBC count and hence expected to provide market with the lucrative growth.
This pregnancy anemia market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Pregnancy Anemia Market Scope and Market Size
Pregnancy anemia market is segmented on the basis of type, treatment, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the pregnancy anemia market is segmented into iron-deficiency anemia, folate-deficiency anemia, vitamin B12 deficiency.
- On the basis of treatment, the pregnancy anemia market is segmented into folic acid supplements, iron supplement, others.
- On the basis of end-users, the Pregnancy anemia market is segmented into clinics, hospitals, homecare, others.
- On the basis of distribution channel, the Pregnancy anemia market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy, others.
Pregnancy Anemia Market Country Level Analysis
Pregnancy anemia market is analysed and market size information is provided by country, type, treatment, end-users and distribution channel as referenced above.
The countries covered in the Pregnancy anemia market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
On geographical estimation, North America accounts the largest market share due to rising trend of smoking among women population who are at higher risk of pregnancy anemia and increase in number of healthcare facilities providing quality healthcare services. Europe accounts the second largest market share second largest market share due to increasing awareness about reproductive health among the public and increasing collaboration and partnership for development of novel therapies. Asia-Pacific is expected to account for the largest market share over coming years for the Pregnancy anemia market due to increasing research and developmental activities for development of novel therapies and increasing investment for development of advanced manufacturing facilities.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Pregnancy anemia market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Pregnancy Anemia Market Share Analysis
Pregnancy anemia market competitive landscape provides details by competitor, details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Pregnancy anemia market.
The major players covered in the Pregnancy anemia market are Spirochem Lifesciences Pvt Ltd., Vifor Pharma Management Ltd., AMAG Pharmaceuticals, Fresenius SE & Co. KGaA, Akebia Therapeutics, CHO-A Pharmaceutical Co., Ltd., LUPIN, Orion Pharma Ltd, SHIELD THERAPEUTICS, Sanofi, Teva Pharmaceutical Industries Ltd., Advanz Pharmaceutical, GlaxoSmithKline plc., Alkem Labs., Hikma Pharmaceuticals PLC, Avion Pharmaceuticals LLC, Allergan, Gland Pharma Limited, PHARMACOSMOS A/S among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-
